Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia
Public ClinicalTrials.gov record NCT00895063. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Studies have suggested that voluntary muscle exercise in the hand and face after botulinum toxin injection may enhance the clinical effects of the toxin. Exercise may speed up the absorption of the toxin by the nerves and enhance the clinical response. This study will explore the effect of exercise on botulinum toxin injections for spasmodic dysphonia (SD).
Study identification
- NCT ID
- NCT00895063
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 8 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2007
- Primary completion
- Apr 30, 2013
- Completion
- Apr 30, 2013
- Last update posted
- Mar 2, 2016
2007 – 2013
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Private Practice of Dr. Andrew Blitzer | New York | New York | 10036 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Spasmodic Dysphonia trials
Other public records listing Spasmodic Dysphonia. Sorted by last update posted; newest first. Not a recommendation.
- NCT07041203: Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor Not yet recruiting
- NCT03042962: Brain Networks in Dystonia Recruiting
- NCT05216770: Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor Recruiting
- NCT05150106: Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor Recruiting
- NCT05150093: Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor Recruiting
- NCT06078527: Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00895063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2016 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00895063 live on ClinicalTrials.gov.